ArticleJCO global oncology2022
Authorship Distribution and Under-Representation of Sub-Saharan African Authors in Global Oncology Publications.
Article in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Hepatitis B Research in Peru, 1988-2023: Geographic Inequities, Thematic Gaps, and Misalignment with Disease Burden.Pathogens (Basel, Switzerland) · 2026Article
- Does ChatGPT enhance equity for global health publications? Copyediting by ChatGPT compared to Grammarly and a human editor.PloS one · 2026Article
- Assessing patterns of authorship of low- and middle-income countries in global commercial clinical trials in oncology.Globalization and health · 2025Article
- Missed Nuances in Tuberculosis Research: Reflections from a Tibetan Scholar.International journal of social determinants of health and health services · 2025Article
- Authorship Inequity in Global Health Research Conducted in Low- and Middle-Income Countries and Published in High-Income Country Family Medicine Journals.Annals of family medicine · 2025Article
- A scoping review of clinical communication in cancer care in Africa.The oncologist · 2025Article
- Network analysis of cross-income-level collaboration on multiple myeloma in sub-Saharan Africa.npj health systems · 2025Article
- Mapping the cancer research landscape across Zambia: evidence to support national cancer control planning.Ecancermedicalscience · 2025Review
- A review of authorship in herpes simplex virus type-2 (HSV-2) research conducted in low-income and middle-income countries between 2000 and 2020.BMJ global health · 2024Review
- Authorship of Publications Supported by NCI-Funded Grants Involving Low- and Middle-Income Countries.JAMA network open · 2024Article
- Assessing Africa's position in the development of AI-enabled ECG devices.F1000Research · 2024Article
- Sex and authorship in global cancer research.BMJ oncology · 2024Article
- An analysis of the African cancer research ecosystem: tackling disparities.BMJ global health · 2023Article
- Bridging the gap: promoting equity and diversity in global oncology research within Sub-Saharan Africa.BMJ oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLocal researchers must be engaged in research conducted in their populations. However, local authors from low- and middle-income countries are often under-represented in global health journals. This report aims to assess and describe the representation of authors in the
methodsThis retrospective cross-sectional study describes data from
resultsOf the 608 articles identified, 420 (69.1%) studied a single country population. Although articles represented studies from all World Bank regions, the sub-Saharan Africa (SSA) region accounted for the highest number (n = 145; 34.5%). In all other regions except SSA, most of the first (66.7%-100%) and last authors (56.6%-95.2%) had primary institutional affiliations based in the same region as the studied country. However, among articles about SSA countries, SSA first authors (n = 65; 44.8%) and last authors (n = 59; 40.7%) were under-represented. In fact, there were more North American first (n = 74; 51.0%) and last authors (n = 72; 49.6%) than SSA authors. There was higher SSA representation among middle authors (n = 97; 68.8%) in studies from the region. A similar trend was also noted with the under-representation of authors from low-income compared with high-income countries.
conclusionSSA authors are under-represented in global oncology articles. Concerted strategies are needed to build local capacity, promote meaningful engagement, and foster equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.